Skip to content
PICO Portalanswers from OpenAlex

Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis

PaperCitations, authors & open-access status

Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis have?

PICO Portalcitation count

Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis has 83 citations in the OpenAlex counts PICO Portal stores.

When was Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis published?

PICO Portalyear

Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis has 2017 year in the PICO Portal index.

What is the open-access status of Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis?

PICO Portaloa status

Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis has bronze oa status in the PICO Portal index.

What is the DOI of Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis?

PICO Portaldoi

The DOI for Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis is on the source record.

What is the PMID of Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis?

PICO Portalpmid

The PMID for Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis is on the source record.

What is the OpenAlex record for Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis?

PICO Portalopenalex

The OpenAlex for Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial